The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 470.00
Bid: 460.00
Ask: 480.00
Change: -10.00 (-2.08%)
Spread: 20.00 (4.348%)
Open: 470.00
High: 480.00
Low: 470.00
Prev. Close: 480.00
TSTL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

6 Apr 2022 12:10

RNS Number : 4981H
Tristel PLC
06 April 2022
 

 

Tristel plc

("Tristel" or the "Company")

Director/PDMR Shareholding

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products announces that, today, Paul Swinney, Chief Executive Officer, purchased 2,350 ordinary shares of 1 penny each in the Company ("Ordinary Shares") at a price of 306.6 pence and Elizabeth Dixon, Chief Financial Officer, purchased 4,000 Ordinary Shares at a price of 306.5 pence.

As a result, Paul Swinney's beneficial interest in the Company is 712,350 Ordinary Shares, representing 1.51 per cent. of the total issued share capital and Elizabeth Dixon's beneficial interest in the Company is 269,000 Ordinary Shares, representing 0.57 per cent. of the total issued share capital.

 

For further information please contact:

 

Tristel plc

Tel: 01638 721 500

Paul Swinney, Chief Executive Officer

Liz Dixon, Finance Director

finnCap Ltd - Nominated Advisor and Broker

Tel: 020 7220 0500

Geoff Nash / Charlie Beeson, Corporate Finance

Alice Lane, ECM

Walbrook PR Ltd

Tel: 020 7933 8780 or tristel@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07854 391 303

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Paul Swinney

2.

Reason for the Notification.

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tristel plc

b)

LEI

2138009DZ4LH9CZGF662

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Ordinary Shares

Identification code

GB00B07RVT99

b)

Nature of the transaction

Purchase of Ordinary shares

 

c)

Price(s) and volume(s)

Price

Volume(s)

306.6 pence

2,350

 

 

 

 

d)

Aggregated information:

- Aggregated volume

- Aggregated price

 

 

 

2,350

£7,205.10

e)

Date of the transaction

06 April 2022

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

5.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Elizabeth Dixon

6.

Reason for the Notification.

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

7.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tristel plc

b)

LEI

2138009DZ4LH9CZGF662

8.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Ordinary Shares

Identification code

GB00B07RVT99

b)

Nature of the transaction

Purchase of Ordinary shares

 

c)

Price(s) and volume(s)

Price

Volume(s)

306.5 pence

4,000

 

 

 

 

d)

Aggregated information:

- Aggregated volume

- Aggregated price

 

 

 

4,000

£12,260

e)

Date of the transaction

06 April 2022

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGZGGDMVDGZZM
Date   Source Headline
1st Dec 201511:06 amRNSPosting of Annual Report & Notice of AGM
1st Dec 201511:05 amRNSFrench study shows superiority of Tristel Wipes
2nd Nov 20153:42 pmRNSIssue of Equity
22nd Oct 20154:02 pmRNSIssue of Equity
15th Oct 20159:50 amRNSIssue of Equity/Director Dealing
12th Oct 20157:00 amRNSFinal Results
5th Oct 20157:00 amRNSInvestor results briefing - Change of venue
1st Oct 20157:00 amRNSAppointment of Non-Executive Director
25th Sep 20151:52 pmRNSIssue of Equity
18th Sep 20157:00 amRNSNotice of Results
18th Aug 201510:14 amRNSIssue of Equity
17th Aug 20151:07 pmRNSDirector Share Transfer
6th Aug 201511:01 amRNSIssue of Equity
4th Aug 201511:57 amRNSDirectors dealing/grant of options
20th Jul 20154:25 pmRNSIssue of Equity
30th Jun 20154:59 pmRNSIssue of Equity
24th Jun 20154:08 pmRNSIssue of Equity
23rd Jun 20153:15 pmRNSIssue of Equity
18th Jun 20159:00 amRNSDirector Dealing/Issue of Equity
18th Jun 20157:00 amRNSSpecial Dividend and notice of results
9th Jun 20151:44 pmRNSTristel welcomes Cardiff University wipes study
3rd Jun 201512:20 pmRNSIssue of Equity
22nd May 201511:19 amRNSIssue of Equity
21st May 20157:00 amRNSTrading update
8th May 20157:00 amRNSIssue of Equity
4th Mar 20157:00 amRNSIssue of Equity/Director dealing
26th Feb 20157:01 amRNSInvestor Presentation
25th Feb 20157:00 amRNSHalf Yearly Report
6th Feb 20157:00 amRNSInvestor Results Presentation
28th Jan 20157:00 amRNSIssue of Equity
24th Dec 201411:27 amRNSGrant of Share Options
23rd Dec 20142:38 pmRNSDirector/PDMR Shareholding
16th Dec 201411:53 amRNSResult of AGM
16th Dec 20147:00 amRNSAGM Statement
21st Nov 20147:00 amRNSPosting of Annual Report & Notice of AGM
17th Nov 20143:27 pmRNSIssue of Equity
11th Nov 20147:00 amRNSNZ ENT study shows Tristel Wipes System benefits
3rd Nov 20146:02 pmRNSDirector's Shareholding
20th Oct 201411:56 amRNSIssue of Equity
13th Oct 20147:00 amRNSFinal Results
29th Sep 20147:00 amRNSInvestor Results Presentation
19th Aug 20147:00 amRNSMarket leadership in UK ENT market
28th Jul 20147:00 amRNSPre-close trading update
7th Jul 201410:03 amRNSIssue of Equity
23rd Jun 20148:30 amRNSIssue of Equity
18th Jun 201411:16 amRNSHolding(s) in Company
10th Jun 20147:00 amRNSTrading Update
22nd May 201412:37 pmRNSIssue of Equity
28th Apr 20147:00 amRNSTrading update
24th Apr 20147:00 amRNSSuccess in controlling Clostridium difficile rates

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.